NASDAQ · Medical - Devices

NUWE (NUWE) Stock

$1.99 -2.93% NASDAQ: NUWE Healthcare

Valuation

MetricValue
Price$1.99
Market Cap$724947
P/E Ratio-0.04
P/B Ratio0.30
P/S Ratio0.10
EPS (TTM)$-25.39
52-Week High$25.95
52-Week Low$0.09
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-600.00%
ROA-300.00%
ROCE-366.67%
Gross Margin-137.50%
Operating Margin-137.50%
Net Margin-2.15%
Debt/Equity0.09
Current Ratio1.67

Annual Financials (USD)

Metric20212022202320242025
Revenue$8.0M$9.0M$9.0M$9.0M$8.0M
Operating Profit$-20.0M$-17.0M$-18.0M$-11.0M$-11.0M
Net Profit$-20.0M$-15.0M$-20.0M$-11.0M$-18.0M
EPS$-10004.09$-2921.95$-360.07$-8.00$-25.39
Op Margin-246.5%-201.0%-198.9%-125.7%-134.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$30.0M$25.0M$10.0M$10.0M$6.0M
Total Liabilities$4.0M$12.0M$7.0M$3.0M$3.0M
Cash$9.0M$18.0M$4.0M$5.0M$1.0M
Borrowings$1.0M$1.0M$1.0M$1.0M$0

Latest News

Nuwellis Secures US Patent for Dual-Lumen Catheter Designed to Improve Extracorporeal Therapies MT Newswires · Jul 16, 2026 Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies GlobeNewswire · Jul 16, 2026 Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026 GlobeNewswire · Jul 7, 2026 Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC⁴) GlobeNewswire · Jun 26, 2026 Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow® Installations GlobeNewswire · Jun 25, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-18.0M$-15.0M$-18.0M$-10.0M$-11.0M
Investing Cash Flow$-16.0M$15.0M$0$0$0
Financing Cash Flow$0$0$0$3.0M$0
Net Cash Flow$-6.0M$9.0M$-14.0M$1.0M$-4.0M
Free Cash Flow$-18.0M$-15.0M$-18.0M$-10.0M$-11.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-1302.54%
Quick Ratio1.09
Interest Coverage-1.00
Return 1Y-98.71%
Return 3Y-100.00%
Return 5Y-100.00%

Ownership

Insiders Held0.01%
Institutions Held1.66%
Institutions Float Held1.66%
Institutional HolderSharesReport Date
Armistice Capital, LLC6,7482026-03-31
Geode Capital Management, LLC1,2622026-03-31
Tower Research Capital LLC (TRC)1482026-03-31
Citigroup Inc.1462026-03-31
SBI Securities Co., Ltd.22026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACON $2.36 -0.84% -0.24 $1.26M 0.00%
BACKIMAC Holdings, Inc. $0.02 +0.00% -0.01 $79484 0.00%
BCTXWBriaCell Therapeutics Corp. $0.00 — 0.00 $1695 0.00%
IVF $0.96 -4.09% -0.01 $1.71M 0.00%
NUVOHoldco Nuvo Group D.G Ltd. Ordinary Shares $0.17 +100.00% -0.10 $5.65M 0.00%

About NUWE

NUWE is led by CEO John L. Erb, employs 38 people, headquartered in US, publicly traded since 2012.

NUWE stock trades at $1.99 with a market capitalization of $724947. The stock is valued at a price-to-earnings (P/E) ratio of -0.04, price-to-book of 0.30, price-to-sales of 0.10. Over the past 52 weeks the stock has ranged between $0.09 and $25.95, and currently trades 92.3% below its 52-week high.

On profitability, NUWE generates a return on equity (ROE) of -600.00%, return on capital employed of -366.67%, an operating margin of -137.50%, a net profit margin of -2.15%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides